Summary of data from test cases of seeding thunderstorms with silver iodide in northeastern Colorado, 1962-63-64

CER64RAS35.December 1964.Progress report, NSF GP-2594, research supported by the Atmospheric Science Program, National Science Foundation.Includes bibliographical references.Under NSF Grant GP-2594

Two Ultra-faint Milky Way Stellar Systems Discovered in Early Data from the DECam Local Volume Exploration Survey

We report the discovery of two ultra-faint stellar systems found in early data from the DECam Local Volume Exploration survey (DELVE). The first system, Centaurus I (DELVE J1238–4054), is identified as a resolved overdensity of old and metal-poor stars with a heliocentric distance of , a half-light radius of , an age of , a metallicity of , and an absolute magnitude of . This characterization is consistent with the population of ultra-faint satellites and confirmation of this system would make Centaurus I one of the brightest recently discovered ultra-faint dwarf galaxies. Centaurus I is detected in Gaia DR2 with a clear and distinct proper motion signal, confirming that it is a real association of stars distinct from the Milky Way foreground; this is further supported by the clustering of blue horizontal branch stars near the centroid of the system. The second system, DELVE 1 (DELVE J1630–0058), is identified as a resolved overdensity of stars with a heliocentric distance of , a half-light radius of , an age of , a metallicity of , and an absolute magnitude of , consistent with the known population of faint halo star clusters. Given the low number of probable member stars at magnitudes accessible with Gaia DR2, a proper motion signal for DELVE 1 is only marginally detected. We compare the spatial position and proper motion of both Centaurus I and DELVE 1 with simulations of the accreted satellite population of the Large Magellanic Cloud (LMC) and find that neither is likely to be associated with the LMC

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

CO-ADMINISTRATION IN A SMALL NEBRASKA PUBLIC SCHOOL

Abstract not availabl